Hematology and Oncology
Home Hematology and Oncology
Outcomes Equal for AYA Hodgkin Therapy at Peds, Adult Centers
Treatment strategies differ, but outcomes equivalent among adolescent, young adult Hodgkin patients
Infection Risk Up in Month After CAR T-Cell Immunotherapy
Infection rates increase in patients with ALL aged ≤26 years in first month, then decrease at days 29 to 90
9.5 Percent Uninsured in U.S. From January Through June 2019
Overall, 13.7 percent of adults aged 18 to 64, 4.4 percent of children aged 0 to 17 were uninsured
Risk for Later Invasive Breast Cancer Up for Women With DCIS
Risks for invasive breast cancer, death from breast cancer higher for up to 20 years following diagnosis
Links Found Between Leaders of Medical Associations, Industry
Most leaders have ties to industry; considerable variation seen among 10 medical associations in U.S.
Early Informed Lung Cancer Patients Have Greater Survival Rates
Predicted survival time for patients who were unaware of their diagnosis was poor
Only One in Four U.S. Hospitals With ICUs Have Tele-ICU Services
Wide regional variation seen for availability of telehealth outpatient visits, tele-ICU services
Lasting Drop Seen in CRC Incidence, Death After Negative Colonoscopy
Reductions only seen for 10.1 to 17.4 years of follow-up after high-quality colonoscopy
Platinum Therapy May Up Survival in Pancreatic Cancer With DNA Repair Defects
PFS longer in pancreatic ductal adenocarcinoma with versus without homologous recombination deficiency
Delays in Cancer Surgery Due to COVID-19 Could Harm Survival
Per-patient delay of three or six months would result in an estimated 92,214 or 208,275 life-years lost
